Remove Equity Remove Invest Remove San Diego Remove Startup
article thumbnail

JMI Equity Backs Jvion's Healthcare AI Software

socalTECH

San Diego- and Baltimore-based private equity investor JMI Equity is the lead backer of a developer of artificial intelligence software for the healthcare industry this morning. The funding was led by JMI Equity, and also included Health Enterprise Partners (HEP) and Health Velocity Capital (HVC). READ MORE>>.

Equity 113
article thumbnail

New VC Firm Blueprint Equity Puts $6M into Florida Software Company

Xconomy

A new venture capital firm, which in November marked its launch by raising a $53 million-plus fund to invest in startups, has made its first investment.

Equity 93
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Southern California Venture Investments Top $1.3 Billion In Q4

socalTECH

Venture capitalists invested more than $1.3 billion in Southern California startup, according to the latest MoneyTree Report issued by PricewaterhouseCoopers and the National Venture Capital Association last night, based on data from Thomson Reuters. billion in investments in Los Angeles, near $125M in Orange County, and $106.6M

article thumbnail

Zesty.io Picks Up $1.5M in Funding

socalTECH

San Diego-based Zesty.io , a startup developing web content management systems, said on Wednesday that it has raised $1.5M The funding came from ClearVision Equity Partners, a local San Diego investors. in a new funding. Zesty.io's CEO is Gerry Widmer. READ MORE>>.

Funding 113
article thumbnail

Upfront Ventures Raised New $280 Million Fund

Both Sides of the Table

The speaks to the continued confidence in the venture capital markets and as I had predicted some time ago the VC markets right now are a great place to invest – especially relative to other places to put one’s money. Our last fund we raised was in 2012 and we began investing it in April of 2012. But that’s it.

article thumbnail

Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis

Xconomy

Empirico, a biotech that has developed tools to analyze genomics data and use those insights to identify potential therapeutic targets, has signed a collaboration deal with antisense drug developer Ionis Pharmaceuticals that includes a $10 million equity investment.

article thumbnail

Inhibrx Finds $40M For Protein Engineering Tools

socalTECH

San Diego-based Inhibrx , a biopharmaceuticals startup working in the area of protein engineering, has raised $40M in an investment from Viking Global Investors, the company announced this mroning.

Tool 100